A New Age in Pediatric Psoriasis: Case-Based Learning for Inclusive Care

Psoriasis is an immune-mediated disease that currently affects more than 8 million Americans and 125 million people worldwide according to the World Psoriasis Day consortium. Symptoms of this disease are characterized by inflammation, commonly presenting as raised plaques and scales on the skin resulting from an overactive immune system. The disease begins in childhood in almost 1/3 of cases, and it is estimated that the incidence of psoriasis in children has more than doubled between 1970 and 2000, making educational initiatives in this area more important now than ever.

Clinicians need up-to-date education regarding new and emerging therapies for psoriasis as well as expert recommendations for use in the pediatric patient population. However, these updated guidelines may still be lacking in terms of recommendations for diagnosing psoriasis in children. Psoriatic lesions in children may differ in distribution and morphology, and clinical symptoms at presentation may vary from those reported by adults. Pediatric patients with skin of color (SOC) may present a challenge to clinicians as there is even greater distribution in the clinical presentation.  It is imperative that clinicians are knowledgeable of the diagnostic criteria for psoriasis in pediatric patients with darker skin types as this disease may cause various physical and psychosocial effects; an early and accurate diagnosis is best for optimal patient outcomes.

This educational activity, originally presented as a satellite symposium at the 31st Annual Masters of Pediatric Dermatology meetings, will equip clinicians with the necessary knowledge to appropriately diagnose and treat pediatric psoriasis patients, across skin types and colors, through evidence and case-based learning.

Target Audience

This activity is designed for an audience of US-based physicians, nurses and allied health providers (nurse practitioners, physician assistants, and pharmacists) who treat pediatric and adolescent patients with dermatological conditions.

Learning Objectives

Upon completion of the educational activity, participants should be able to:

  • Identify key clinical features for accurate diagnosis of psoriasis in pediatric patients across skin types.
  • Review the efficacy and safety of current and emerging therapies for pediatric psoriasis.
  • Develop individualized treatment plans for pediatric patients with moderate-to-severe psoriasis.
Course summary
Available credit: 
  • 1.00 AAPA Category I CME
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 Participation
Course opens: 
05/15/2023
Course expires: 
05/15/2024
Rating: 
0
  • Introduction
  • Diagnosing Psoriatic Lesions in Pediatric SOC
  • What’s New in the Toolbox for Pediatric Psoriasis?
  • Interpreting the Evidence to Practice: Patient Cases
  • Concluding Remarks

Latanya T. Benjamin, MD, FAAD, FAAP

Associate Professor of Dermatology

Florida Atlantic University

Boca Raton, FL

Adelaide A. Hebert, MD

Chief of Pediatric Dermatology

UTHealth McGovern Medical School

Children's Memorial Hermann Hospital

Houston, TX

Credit provided by AKH Inc., Advancing Knowledge in Healthcare

In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and Tarsus Cardio dba LiVDerm. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

Physician

AKH Inc., Advancing Knowledge in Healthcare designates this enduring material activity for a maximum of 1  AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Nurse

1 ANCC contact hours.

 

Physician Assistant

 AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credits. Approval is valid until 5/15/2024. PAs should only claim credit commensurate with the extent of their participation.

 

Pharmacists

AKH Inc., Advancing Knowledge in Healthcare designates this continuing education activity for 1 contact hours.

 

Commercial Support
This activity is supported by an educational grant from Arcutis Biotherapeutics, Inc.

 

DISCLOSURES

 

 

Name

Relationship(s)

Organization(s)

Latanya Benjamin, M, FAAP

Speaker

Sanofi Genzyme and Regeneron

Adelaide Hebert, MD

N/A

Nothing to Disclose

Dorothy Caputo, MA, BSN, RN, Senior Director of Continuing Education & Compliance

N/A

Nothing to disclose

Michele Bielarski, RN (planner/reviewer)

N/A

Nothing to disclose

Dorothy Duffy, RPh, Pharmacy Reviewer

N/A

Nothing to disclose

AKH Inc Staff and Planners

N/A

Nothing to disclose

Tarsus dba LiVDerm Staff and Planners

N/A

Nothing to disclose

All of the relevant financial relationships listed for these individuals have been mitigated.



Disclosures

It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.

 

Disclosure of Unlabeled Use and Investigational Product

This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

 

Disclaimer

This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant’s misunderstanding of the content.

 

AKH Privacy Policy (link: https://akhcme.com/akhcme/pages/privacy)

Available Credit

  • 1.00 AAPA Category I CME
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 Participation
Please login or register to take this course.

Required Hardware/software

A computer with an internet connection

Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser

Other additional software may be required such as PowerPoint or Adobe Acrobat Reader.

AKH Privacy Policy (link: https://akhcme.com/akhcme/pages/privacy